Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Metformin as an Anticancer Agent
Aleš Vančura, Pengli Bu, Madhura Bhagwat, et al.
Trends in Pharmacological Sciences (2018) Vol. 39, Iss. 10, pp. 867-878
Open Access | Times Cited: 234

Showing 26-50 of 234 citing articles:

Mitochondrial dysfunction at the crossroad of cardiovascular diseases and cancer
Carmine Rocca, Teresa Soda, Ernestina Marianna De Francesco, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 33
Phosphorylation of PHF2 by AMPK releases the repressive H3K9me2 and inhibits cancer metastasis
Ying Dong, Hao Hu, Xuan Zhang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 28
Autophagy Modulators: Mechanistic Aspects and Drug Delivery Systems
Shima Tavakol, Milad Ashrafizadeh, Shuo Deng, et al.
Biomolecules (2019) Vol. 9, Iss. 10, pp. 530-530
Open Access | Times Cited: 69
Metformin and Breast Cancer: Molecular Targets
João Faria, G. Negalha, Ana Azevedo, et al.
Journal of Mammary Gland Biology and Neoplasia (2019) Vol. 24, Iss. 2, pp. 111-123
Closed Access | Times Cited: 68
Mitochondrial Metabolism in PDAC: From Better Knowledge to New Targeting Strategies
Gabriela Reyes‐Castellanos, Rawand Masoud, Alice Carrier
Biomedicines (2020) Vol. 8, Iss. 8, pp. 270-270
Open Access | Times Cited: 61
The role of an anti-diabetic drug metformin in the treatment of endocrine tumors
Shilpa Thakur, Brianna Daley, Joanna Kłubo-Gwieździńska
Journal of Molecular Endocrinology (2019) Vol. 63, Iss. 2, pp. R17-R35
Open Access | Times Cited: 55
Therapeutic Repurposing of Biguanides in Cancer
Hongyun Zhao, Kenneth D. Swanson, Bin Zheng
Trends in cancer (2021) Vol. 7, Iss. 8, pp. 714-730
Open Access | Times Cited: 53
The Use of Metformin to Increase the Human Healthspan
Veronika Piskovatska, Kenneth B. Storey, Alexander Vaiserman, et al.
Advances in experimental medicine and biology (2020), pp. 319-332
Closed Access | Times Cited: 52
Metformin enhances anti-cancer effects of cisplatin in meningioma through AMPK-mTOR signaling pathways
Liemei Guo, Jing Cui, Herui Wang, et al.
Molecular Therapy — Oncolytics (2020) Vol. 20, pp. 119-131
Open Access | Times Cited: 51
Visceral Obesity Promotes Lung Cancer Progression—Toward Resolution of the Obesity Paradox in Lung Cancer
Joseph Barbi, Santosh K. Patnaik, Sarabjot Pabla, et al.
Journal of Thoracic Oncology (2021) Vol. 16, Iss. 8, pp. 1333-1348
Open Access | Times Cited: 48
Anti‐diabetic drugs and sarcopenia: emerging links, mechanistic insights, and clinical implications
Xueli Zhang, Yi Zhao, Shuobing Chen, et al.
Journal of Cachexia Sarcopenia and Muscle (2021) Vol. 12, Iss. 6, pp. 1368-1379
Open Access | Times Cited: 47
The Dual-Role of Methylglyoxal in Tumor Progression – Novel Therapeutic Approaches
Alessia Leone, Cecilia Nigro, Antonella Nicolò, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 42
Genome-wide CRISPR screen identifies synthetic lethality between DOCK1 inhibition and metformin in liver cancer
Junru Feng, Hui Lü, Wenhao Ma, et al.
Protein & Cell (2022) Vol. 13, Iss. 11, pp. 825-841
Open Access | Times Cited: 37
Molecular biological mechanism of action in cancer therapies: Juglone and its derivatives, the future of development
Yu-Ting Tang, Yang Li, Peng Chu, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 148, pp. 112785-112785
Open Access | Times Cited: 35
The evolving view of thermogenic fat and its implications in cancer and metabolic diseases
Xinpeng Yin, Yuan Chen, Rexiati Ruze, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 34
Metformin: Activation of 5′ AMP-activated protein kinase and its emerging potential beyond anti-hyperglycemic action
S. K. Goel, Ravinder Pal Singh, Varinder Singh, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 33
TME-triggered MnSiO3@Met@GOx nanosystem for ATP dual-inhibited starvation/chemodynamic synergistic therapy
Jiayao Zhang, Liang Chen, Ziye Wei, et al.
Biomaterials (2022) Vol. 287, pp. 121682-121682
Closed Access | Times Cited: 30
Single cell mass spectrometry analysis of drug-resistant cancer cells: Metabolomics studies of synergetic effect of combinational treatment
Xingxiu Chen, Mei Sun, Zhibo Yang
Analytica Chimica Acta (2022) Vol. 1201, pp. 339621-339621
Open Access | Times Cited: 28
Repurposing drugs targeting metabolic diseases for cancer therapeutics
Jisha Pillai U, Anindita Ray, Meenu Maan, et al.
Drug Discovery Today (2023) Vol. 28, Iss. 9, pp. 103684-103684
Closed Access | Times Cited: 18
Metformin Suppresses Both PD-L1 Expression in Cancer Cells and Cancer-Induced PD-1 Expression in Immune Cells to Promote Antitumor Immunity
Su Hwan Park, J.H. Lee, Hye Jin Yun, et al.
Annals of Laboratory Medicine (2024) Vol. 44, Iss. 5, pp. 426-436
Open Access | Times Cited: 6
Respiratory complex I regulates dendritic cell maturation in explant model of human tumor immune microenvironment
Rita Turpin, Ruixian Liu, Pauliina Munne, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 4, pp. e008053-e008053
Open Access | Times Cited: 6
Metformin prevents the pathological browning of subcutaneous white adipose tissue
Christopher Auger, Carly M. Knuth, Abdikarim Abdullahi, et al.
Molecular Metabolism (2019) Vol. 29, pp. 12-23
Open Access | Times Cited: 49
Reducing PD-L1 expression with a self-assembled nanodrug: an alternative to PD-L1 antibody for enhanced chemo-immunotherapy
Shuxian Cai, Ziyi Chen, Yingjie Wang, et al.
Theranostics (2020) Vol. 11, Iss. 4, pp. 1970-1981
Open Access | Times Cited: 48
Metformin Suppresses Self-Renewal Ability and Tumorigenicity of Osteosarcoma Stem Cells via Reactive Oxygen Species-Mediated Apoptosis and Autophagy
Bin Zhao, Jie Luo, Ye Wang, et al.
Oxidative Medicine and Cellular Longevity (2019) Vol. 2019, pp. 1-18
Open Access | Times Cited: 43
Metabolic heterogeneity in cancer: An overview and therapeutic implications
Tong Yu, Wei‐Qiang Gao, Yanfeng Liu
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2020) Vol. 1874, Iss. 2, pp. 188421-188421
Closed Access | Times Cited: 40

Scroll to top